News
GC Biopharma has partnered with Körber to implement a large-scale Manufacturing Execution System (MES) project across ...
This designation highlights the potential of Cellino’s automated technology for scaling up high-quality iPSCs to industrialize next-generation regenerative therapies. Autologous ...
The U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Novavax Inc.’s Nuvaxovid.
Rznomics Inc., a South Korea-based biopharmaceutical company specializing in RNA-based therapeutics, has entered into a ...
BioMarin has entered into a definitive agreement to acquire Inozyme Pharma Inc. for a total consideration of approximately ...
Lars Fruergaard Jørgensen will step down from his role as CEO of Novo Nordisk. In the meantime, a search for Jørgensen’s ...
The new board will work with Abzena's scientific and commercial leadership to provide strategic guidance and insights.
Manufacturing company groninger is investing over $14 million in new headquarters at its U.S. location in Charlotte, N.C.
FAMAR Group, a CDMO, has signed an agreement to acquire a sterile production site in Homburg, Germany, from MiP Pharma.
Aptamer Group plc has announced two new development contracts for its Optimer binders and a licensing heads of terms ...
What’s at stake in the face the enforcement deadlines and how exception management lays the groundwork for future-ready ...
Septerna, Novo Nordisk partner to discover, develop and commercialize oral small molecule medicines for cardiometabolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results